Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA4 | P22748 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7976367 | 0.85 | TUBB1 (0.41) | ALDH1A1TUBB1ACHECYP3A4MAPT | |
| SCHEMBL1099372 | 0.85 | ACHE (0.36) | ALDH1A1TUBB1TDP1ACHEHSD17B10 | |
| SCHEMBL16256381 | 0.85 | ACHE (0.36) | ALDH1A1TUBB1TDP1ACHECYP3A4 | |
| SCHEMBL6739577 | 0.83 | TUBB1 (0.35) | ALDH1A1TUBB1TDP1ACHEHSD17B10 | |
| SCHEMBL2036050 | 0.83 | TDP1 (0.44) | ALDH1A1TUBB1TDP1CYP3A4MAPT | |
| SCHEMBL31210105 | 0.83 | TUBB1 (0.32) | ALDH1A1TUBB1TDP1ACHEHSD17B10 | |
| SCHEMBL9149201 | 0.83 | HSD17B10 (0.38) | ALDH1A1TUBB1TDP1ACHEHSD17B10 | |
| SCHEMBL1099369 | 0.83 | TUBB1 (0.32) | ALDH1A1TUBB1TDP1ACHEHSD17B10 | |
| SCHEMBL31015964 | 0.83 | CA2 (0.41) | ALDH1A1TUBB1HSD17B10CA2CA1 | |
| SCHEMBL135396 | 0.83 | TUBB1 (0.32) | ALDH1A1TUBB1TDP1ACHEHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466717-A | Fully substituted alkyl alkenyl ether, preparation method and application | 四川大学 | 2024-01-30 | — | — | CN | claimed |
| CN-116162236-A | Preparation method of branched polyaryletherketone resin, branched polyaryletherketone resin and application of branched polyaryletherketone resin in gas separation membrane | 中国科学院大连化学物理研究所 | 2023-05-26 | — | — | CN | claimed |
| US-11063297-B2 | Electrochemical cell and electrolyte for same | Viking Power Systems Pte, Ltd. (SG) | 2021-07-13 | — | — | US | claimed |
| CN-112490015-A | Asymmetric high-voltage super capacitor | 西安合容新能源科技有限公司 | 2021-03-12 | — | — | CN | claimed |
| CN-107681197-B | Electrolyte for lithium-sulfur battery | 西安科技大学 | 2020-02-14 | — | — | CN | claimed |
| US-20190198932-A1 | ELECTROCHEMICAL CELL AND ELECTROLYTE FOR SAME | PELLION TECHNOLOGIES INC. (US) | 2019-06-27 | — | — | US | claimed |
| US-20190198933-A1 | ELECTROCHEMICAL CELL AND ELECTROLYTE FOR SAME | PELLION TECHNOLOGIES INC. (US) | 2019-06-27 | — | — | US | claimed |
| CN-104478669-A | Asymmetric terphenyl liquid crystal compound | UNIV SHIHEZI | 2015-04-01 | — | — | CN | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| US-12637438-B2 | Protoporphyrinogen oxidase inhibitors | ENKO CHEM, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| CN-119859091-A | Synthesis method of indene alkyl substituted polyfluoroaromatic hydrocarbon | 南通大学 | 2025-04-22 | — | — | CN | disclosed |
| US-20250084044-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | ENKO CHEM, INC. (US) | 2025-03-13 | — | — | US | disclosed |
| EP-4462999-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | Enko Chem, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| CN-118541030-A | Protoporphyrinogen oxidase inhibitors | 恩科化学公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-1229791-A | Ester compounds | SUMITOMO CHEMICAL CO (JP) | 1999-09-29 | — | — | CN | disclosed |
| EP-0851524-A1 | Non-aqueous electrolyte secondary cell | SONY CORPORATION (JP) | 1998-07-01 | — | — | EP | disclosed |
| CN-1180705-A | Method for producing [ fluoroaryl ] boron compound and method for producing tetrakis [ fluoroaryl ] boron derivative | NIPPON CATALYTIC CHEM IND (JP) | 1998-05-06 | — | — | CN | disclosed |
| EP-0838466-A2 | Producing process of (fluoroaryl) borane compound and producing process of tetrakis (fluoroaryl) borate derivative | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-04-29 | — | — | EP | disclosed |
| EP-0825195-A1 | PROCESS FOR THE PREPARATION OF FLUORINATED ARYLMAGNESIUM DERIVATIVES AND PROCESS FOR THE PREPARATION OF (FLUORINATED ARYL)BORON COMPOUNDS | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-02-25 | — | — | EP | disclosed |
| EP-0778264-A1 | Tertiary amines having antimycotic and cholesterol lowering activity | F. HOFFMANN-LA ROCHE AG (CH) | 1997-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084044-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | PPOX, CYP4X1, PNPO | ALDH1A1 1008/4885TUBB1 644/4885TDP1 862/4885 |
| US-12637438-B2 | Protoporphyrinogen oxidase inhibitors | PPOX, CYP4X1, CBR3 | ALDH1A1 741/4885TUBB1 1033/4885TDP1 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.